Drupal.behaviors.print = function(context) {window.print();window.close();}>

Alnylam RNAi IP Upheld in European Opposition Proceedings

December 02, 2010

Alnylam RNAi IP Upheld in European Opposition Proceedings

Alnylam said that opponents to the patent included Merck subsidiary Sirna Therapeutics, Silence Therapeutics, Pfizer, and BASF.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories